We are a microfluidics company that has developed a method of targeting and lysing single cells in a complex background of other cells for –omics based analysis of the single cells. We are applying this technology to isolating fetal cells from PAP-smear samples to develop a minimal invasive prenatal genetic diagnostic test.


Team Members

Dean Chamberlain
Chief Science Officer

Michael Dryden
Chief Technology Officer

Julian Lamanna
VP Product Development

Aaron Wheeler